Abstract:
PURPOSE: An external use skin composition containing a Sanguisorba tenuifolia Fisch. ex Link extract is provided to suppress tyrosinase activity and melanogenesis, thereby having excellent whitening effect. CONSTITUTION: An external use skin composition contains 0.001-50 wt% of a Sanguisorba tenuifolia Fisch. ex Link extract as an active ingredient. The composition is used for skin whitening. The composition contains a skin absorption promoting material for enhancing skin whitening effect.
Abstract:
PURPOSE: An external use skin composition containing a Glehnia littoralis Fr. Schmidt extract is provided to ensure an excellent antioxidative effect. CONSTITUTION: An external use skin composition contains 0.001- 50 wt% of a Glehnia littoralis Fr. Schmidt extract as an active ingredient. The composition is used for antioxidation, skin elasticity, and anti-wrinkling.
Abstract:
PURPOSE: An external use skin composition containing an E. gracilistylus extract is provided to ensure antioxidation and skin moisturization. CONSTITUTION: An external use skin composition contains 0.001-50 wt% of an E. gracilistylus extract as an active ingredient. The composition is used for antioxidation, skin elasticity, anti-wrinkling, and moisturization.
Abstract:
본 발명은 자외선, 환경 오염 등 노화를 촉진시키는 외부 유해 환경 인자에 대응하여 피부 노화 현상을 억제할 수 있는 화장료 조성물에 관한 것으로, 보다 상세하게는 녹차 다당체(Green tea polysaccharide) 및 송이버섯(Tricholoma matsutake) 추출물을 함유하여 피부 염증 및 산화 현상을 억제함으로써 항노화 효과가 탁월한 화장료 조성물에 관한 것이다. 녹차 다당체, 송이버섯 추출물, 외부유해환경, 환경 오염, 항염, 항산화, 항노화
Abstract:
PURPOSE: A cosmetic composition containing Phyllanthus urinaria extract and stabilized polymersomes is provided to enhance anti-wrinkling, skin elasticity, and skin moisturizing. CONSTITUTION: A cosmetic composition for improving skin elasticity contains a stabilized polymersomes as an active ingredient, containing Phyllanthus urinaria extract and anti-aging peptides. The anti-aging peptides are palmitoyl tripeptide-5 or diaminopropionoyl triepeptide-33. The stabilized polymersom is ABcell.
Abstract:
PURPOSE: A method for extracting medicinal herb ingredients by a process of steaming medicinal herb ingredients with white rice is provided to reduce cytotoxicity and to relieve skin irritation. CONSTITUTION: A method for extracting medicinal herb ingredients using rice steaming comprises a step of steaming the medicinal herb ingredients together with white rice; and a step of extracting medicinal herb ingredients using organic solvent such as ethanol, methanol, butanol, ether, ethyl acetate, and chloroform at 10-80°C for 6-24 hours. The medicinal herbs are Angelicae dahuricae Radix, Cynanchi Wilfordii Radix, Ginkgo Semen, or Paeonia japonica. An external use skin composition containins the medicinal herb extract.
Abstract:
PURPOSE: A cosmetic composition containing cyclic lipopeptide is provided to suppress MMP-1 expression and to treat skin wrinkling. CONSTITUTION: A cosmetic composition contains 0.0001-30 weight% of iturin A or surfactin as an active ingredient. The iturin A or surfactin is a cyclic lipopeptide isolated from Bacillus sp. The iturin A or surfactin is used in health food additive and drug composition.
Abstract:
A kit for predicting chloasma is provided to predict rapidly and sensitively potentialities of forming chloasma from skin by 23 kinds of genes highly revealed and 5 kinds of genes lowly revealed near the chloasma region. A kit for predicting chloasma comprises one or more monoclonal antibodies having the amino acid sequence coded by a gene selected from a group consisting of PCOLCE2, GFPT2, CCL21, WIF1 and H19 as a variable region. If an amount of the antigen combined in the antibody is less than a normal value, it is diagnose as the skin in which the chloasma is easily formed.
Abstract:
A skin whitening composition with excellent whitening effect is provided to be able to effectively inhibit melanogenesis without side effects by comprising deoxymannojirimycin, which is mannosidase inhibitor, only or the deoxymannojirimycin and deoxynojirimycin in combination. The composition for skin whitening comprises deoxymannojirimycin as an effective ingredient. The composition further comprises deoxynojirimycin as an effective ingredient. Regarding the total weight of the composition, 0.001-20 wt.% of the effective ingredient is contained.